Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17460 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, 2023. Written by Yusuf Yilmaz. Institution: Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease. Cited 2 times so far (Crossref); 10 references.
Abstract (original language)
LINKED CONTENT This article is linked to Ajmera et al papers. To view these articles, visit https://doi.org/10.1111/apt.17452 and https://doi.org/10.1111/apt.17478
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
- Institute of Gastroenterology, Marmara University, İstanbul, Turkey.
ORCID profiles: Yusuf Yilmaz
Cite
APA
Yilmaz, Y. (2023). Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17460
Vancouver
Yilmaz Y. Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17460
BibTeX
@article{Yilmaz2023,
author = {Yilmaz, Yusuf},
title = {Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17460}
}
EUVIMED